Data and Safety Monitoring Board (DSMB) Training 2026
Application is call: Data and Safety Monitoring Board (DSMB) Training 2026
The Africa Centres for Disease Control and Prevention (Africa CDC) is an autonomous institution of the African Union that supports the Member States (MS) in planning, preparing and responding to the health threats
- and disease outbreaks on the continent. Its work is guided by the leadership principles of credibility, ownership, delegated authority, the timely dissemination of information, transparency, accountability and value addition.
- Among the units at Africa CDC is the Science and Innovation division whose mandate includes ensuring effective safety monitoring in clinical trials to uphold ethical research standards and protect participant well-being.
Adverse events can arise during the administration of investiga-tional products, requiring rigorous oversight to assess risks and ensure timely interventions. The Data and Safety Monitoring Board (DSMB) plays a vital role in reviewing clinical trial data, safe-guarding trial participants and maintaining the integrity of study results.
To strengthen DSMB ex-pertise across the continent, Africa CDC, in collaboration with the Safety Platform for Emergency Vaccines (SPEAC), is offering a structured training course in data safety monitoring.
Eligibility
The training is open to professionals working in:
- Vaccine safety surveillance organisations
- Clinical trial hubs
- National Regulatory Authorities (NRAs) National PV centres
- Ethics committees
- Applicants should have a background in clinical trials or vaccine pharmacovigilance.
Trainers and Facilitators
The course will be led by a team of experiencedvtrainers from the Safety Platform for Emergency Vaccines (SPEAC), a CEPI-funded initiative to enhance safety for CEPI-funded trials across various platforms for multiple priority pathogens.
Certification Requirements:
To receive a Certificate of Completion in Safety Monitoring in Clinical Trials, participants must:
- Achieve a passing score of 70% in all quizzes.
- Actively participate in all live sessions (maximum of two absences permitted).
- Score 70% or higher on the final exam (two attempts allowed).
Registration and Participant Selection
Course start date: February 12, 2026
Registration Deadline: January 31, 2026
Required Application Details:
- Full Name, Country of Residence, Current Position, vaccine, DSMB and clinical trial related experience, Curriculum Vitae, Contact Information (Phone & Email).
Application Deadline :31 January 2026
Method Of Application
- All applications must be submitted using the online application form. Incomplete applications will not be considered.
All applicants must provide the following required information:
A support letter from the current employer
- Letters of recommendation from two reputable professional referees.
- A personal statement (maximum 500 words) demonstrating the candidate’s commitment to medicine safety in Africa.
This statement should outline the applicant’s technical qualifications, professional experience and achievements, and articulate their vision for the future impact of effective medicine safety and regulation systems across the continent.
How to Apply
Click on the link here: Apply Now
Selection Process
A total of 40 participants will be chosen for each course based on their professional background, relevant experience and geographical representation to ensure a diverse cohort,
 Training 2026){kind=link}
إرسال تعليق